By Nathalie Strub-Wourgaft, Director of Neglected Tropical Diseases (NTDs) and COVID-19 Response, DNDi
With the first results of multiple Covid-19 vaccine candidates giving hope to billions of people around the world, the power of biomedical research has captured the public’s attention. The speed with which it moved to develop vaccines, treatments, and diagnostic tests has been impressive — although equitable access to these innovations is still unsure.
